BOSTON and SAN DIEGO, July 23, 2025 (GLOBE NEWSWIRE) -- Ikena Oncology, Inc. (Nasdaq: IKNA) (“Ikena”

Swiss healthcare firm Roche has said its US$1.5 billion takeover of US biopharmaceutical company Pos

Roche on Wednesday said it planned to complete its purchase of U.S. biopharmaceutical company Poseid

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether t

Poseida Therapeutics (PSTX) is at a 52-week high, but can investors hope for more gains in the futur

Additional new profiling of patient responses from the optimized lymphodepletion arm (Arm C) show co

From a technical perspective, Poseida Therapeutics, Inc. (PSTX) is looking like an interesting pick,

NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and th

The consensus price target hints at a 49.3% upside potential for Poseida Therapeutics (PSTX). While

Poseida Therapeutics (PSTX) is at a 52-week high, but can investors hope for more gains in the futur

NEW YORK , Nov. 26, 2024 /PRNewswire/ -- Monteverde & Associates PC (the "M&A Class Action Firm"), h

Shares of Poseida Therapeutics Inc (NASDAQ: PSTX) more than tripled this morning after Roche Holding

Poseida Therapeutics, a cell therapy company, is being acquired by Roche in a $1.5 billion deal.

MILWAUKEE--(BUSINESS WIRE)--Ademi LLP is investigating Poseida (Nasdaq: PSTX) for possible breaches

On Tuesday, Roche Holdings AG RHHBY agreed to acquire Poseida Therapeutics, Inc. PSTX for an equity

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether t

Roche will acquire California-based biopharmafirm Poseida Therapeutics for $9 per share at closing,

Poseida stockholders to receive up to $13.00 per share in cash, comprised of $9.00 per share in cash

Emerging leadership in allogeneic CAR-T for hematologic malignancies demonstrated by recent P-BCMA-A

Does Poseida Therapeutics, Inc. (PSTX) have what it takes to be a top stock pick for momentum invest

Shares of Mesoblast Limited (NASDAQ: MESO) rose sharply during Monday’s session after the company a

U.S. stocks were lower, with the Dow Jones index falling more than 150 points on Monday.

Gainers Tango Therapeutics, Inc. (NASDAQ: TNGX) climbed 85.2% to $7.09 after gaining 11% on Tuesd

Gainers Vistagen Therapeutics, Inc. (NASDAQ: VTGN) shares jumped 747.6% to $14.24 after the comp

Gainers Barnes & Noble Education, Inc. (NYSE: BNED) jumped 39% to $2.39 after the company pos

Gainers InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV) shares jumped 178.5% to $12.45 after g

Here's a roundup of top developments in the biotech space over the last 24 hours:

Gainers Missfresh Limited (NASDAQ: MF) shares rose 112.9% to $0.2450 in pre-market trading after

Gainers Quoin Pharmaceuticals, Ltd. (NASDAQ: QNRX) shares surged 360.5% to settle at $19.80 on We

Gainers Helius Medical Technologies, Inc. (NASDAQ: HSDT) shares jumped 167% to $1.72 after droppi

Gainers AeroClean Technologies, Inc. (NASDAQ: AERC) gained 154.7% to settle at $12.10 on Tuesday

  On Wednesday, 807 companies reached new 52-week lows.

  On Friday, 1043 companies hit new 52-week lows.

  During Thursday, 849 stocks hit new 52-week lows.

  During Tuesday, 581 stocks hit new 52-week lows. Interesting Highlights From Today's 52-Week

  On Friday, 431 companies hit new 52-week lows.

    On Friday, 313 companies hit new 52-week lows.

    On Thursday, 147 companies achieved new lows for the year.

    During Monday's session, 291 companies made new 52-week lows. Also check out this: Insid

    During Wednesday's morning trading, 400 companies set new 52-week lows.

  During Friday's session, 445 companies made new 52-week lows.

Gainers